Institutional investors purchased a net $295.4 thousand shares of MESO during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 2.99% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PENBROOK MANAGEMENT LLC Bought 235.6 Thousand shares of Mesoblast Ltd